Global orphan drugs market led by Roche's rituximab The Pharma Letter The prize for the top selling drug went to rituximab, an oncology treatment sold by Swiss drug major Roche (ROG: SIX) which sell it under the trade name Rituxan. This drug has present day peak sales value of $7 billion and a discounted peak value of ... |
